Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc (NQ: POAI )

3.158 -0.202 (-6.00%)
Streaming Delayed Price Updated: 12:51 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,000
Open 3.390
Bid (Size) 3.150 (1)
Ask (Size) 3.200 (1)
Prev. Close 3.360
Today's Range 3.150 - 3.390
52wk Range 2.470 - 13.88
Shares Outstanding 4,005,230
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
Via InvestorPlace

Performance

YTD
-50.09%
-50.09%
1 Month
-6.83%
-6.83%
3 Month
-53.37%
-53.37%
6 Month
-60.51%
-60.51%
1 Year
-64.83%
-64.83%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Present Groundbreaking PEDAL Approach at 2023 BIO International Convention
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
From Predictive Oncology Inc.
Via GlobeNewswire
Nasdaq Edges Higher; Home Depot Posts Downbeat Sales
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Releases Q1 2023 Financial Report, Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
From Predictive Oncology Inc.
Via GlobeNewswire
Earnings Scheduled For May 15, 2023
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) to Report First Quarter 2023 Results, Host Conference Call and Webcast
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Undiscovered AI Stocks Set to Dominate the Market
Via InvestorPlace
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
From Predictive Oncology Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
Via Benzinga
Why Predictive Oncology Stock Is Getting Hammered
Via Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reverse Stock Split Approved, Effective April 24
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Sidus Space Shares Are Trading Lower By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Predictive Oncology Announces Reverse Stock Split
From Predictive Oncology Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.